Matusali G. et al. reported persistent levels of anti-trimeric S IgG and anti-RBD IgG up to 6 months after the second COVID-19 vaccine dose with the anti-RBD IgG Abs presenting a steeper decay [26]. The gene discussed is DDX41; the disease is COVID-19.